Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Yang-Chun Gu · SciRah

Researcher profile · Semantic Scholar

Yang-Chun Gu

Share profile

Yang-Chun Gu — researcher profile on SciRah

h-index: 8
Works: 30
Citations: 173

Most-cited papers

Immune checkpoint inhibitor‐related adverse events in lung cancer: Real‐world incidence and management practices of 1905 patients in China
Yuequan Shi, Jian Fang, Cheng-Zhi Zhou, An-Wen Liu +30 more
2021Thoracic Cancer33 citations Open access
Semantic Scholar
Real‐world data on EGFR/ALK gene status and first‐line targeted therapy rate in newly diagnosed advanced non‐small cell lung cancer patients in Northern China: A prospective observational study
Hong-Ge Liang, Xia Song, Yu-Hui Zhang, Shu-Cai Zhang +22 more
2019Thoracic Cancer23 citations Open access
Semantic Scholar
Osimertinib versus comparator first-generation epidermal growth factor receptor tyrosine kinase inhibitors as first-line treatment in patients with advanced EGFR-mutated non-small cell lung cancer: a Chinese, multicenter, real-world cohort study
Dong-Min Zhang, Xiao-Yan Liu, Fangfang Shen, Dahai Zhao +36 more
2023Translational Lung Cancer Research21 citations Open access
Semantic Scholar
Transformation to small cell lung cancer and activation of KRAS during long-term erlotinib maintenance in a patient with non-small cell lung cancer: A case report.
Yang-Chun Gu, Xiang Zhu, Bao-Shan Cao, Xue Wu +3 more
2019Oncology Letters14 citations Open access
Semantic Scholar
Value and significance of brain radiation therapy during first‐line EGFR‐TKI treatment in lung adenocarcinoma with EGFR sensitive mutation and synchronous brain metastasis: Appropriate timing and technique
Yang-Chun Gu, Yan Xu, H. Zhuang, Wei-Juan Jiang +14 more
2021Thoracic Cancer11 citations Open access
Semantic Scholar
Treatment-Related Adverse Events with PD-1 or PD-L1 Inhibitors: A Systematic Review and Meta-Analysis
Yixi Zhang, Bin La, Baosheng Liang, Yang-Chun Gu
2021Life9 citations Open access
Semantic Scholar
Different patterns of treatment‐related adverse events of programmed cell death‐1 and its ligand‐1 inhibitors in different cancer types: A meta‐analysis and systemic review of clinical trials
Yang-Chun Gu, Hua Zhang, Zexiang Liu, Yi-Fan Xia +2 more
2020Asia-Pacific Journal of Clinical Oncology9 citations
Semantic Scholar
治疗前后NLR和PLR对进展期非小细胞肺癌一线化疗疗效及预后的预测价值
F. Yi, Yang-Chun Gu, Sen Chen, Yan'e Liu +3 more
2018Zhongguo fei ai za zhi = Chinese journal of lung cancer9 citations
Semantic Scholar
Clinical outcomes of advanced NSCLC patients with different EGFR exon 19 deletion subtypes treated with first‐line tyrosine kinase inhibitors: A single‐center ambispective cohort study
Yang-Chun Gu, Jin-Yu Yu, Haifeng Hu, Hua Zhang +2 more
2023Thoracic Cancer7 citations Open access
Semantic Scholar
Alectinib as first-line treatment for advanced ALK-positive non-small cell lung cancer in the real-world setting: preliminary analysis in a Chinese cohort
Z. Zou, Yang-Chun Gu, Li Liang, X. Hao +20 more
2022Translational Lung Cancer Research6 citations Open access
Semantic Scholar
Blood T cell diversity associated with the prognosis of advanced non‐small cell lung carcinoma treated with first‐line pemetrexed based chemotherapy
Qian Li, Z. Zhang, Yaping Xu, Zhen-Tian Liu +9 more
2021Thoracic Cancer5 citations Open access
Semantic Scholar
Clinical outcome, long‐term survival and tolerability of sequential therapy of first‐line crizotinib followed by alectinib in advanced ALK+NSCLC: A multicenter retrospective analysis in China
Z. Zou, X. Hao, Cui-Ying Zhang, Haojing Li +10 more
2021Thoracic Cancer5 citations Open access
Semantic Scholar
Dilemma and solutions of treatment delay in cancer patients during the COVID‐19 pandemic: A single‐center, prospective survey
Yan'e Liu, Yanhong Yao, Qi-Qi Wang, Zhen-Tao Liu +4 more
2021Asia-Pacific Journal of Clinical Oncology5 citations
Semantic Scholar
Impact of EML4‐ALK Variants and TP53 Status on the Efficacy of ALK Inhibitors in Patients With Non‐small Cell Lung Cancer
Z. Zou, Li-Ge Wu, X. Hao, Yan Li +5 more
2025Thoracic Cancer4 citations Open access
Semantic Scholar
283例系统性治疗的肺癌患者静脉血栓栓塞症的危险因素分析
Yan'e Liu, Yang-Chun Gu, F. Yi, Bao-Shan Cao
2019Zhongguo fei ai za zhi = Chinese journal of lung cancer3 citations
Semantic Scholar
Characteristics and Clinical Implication of UGT1A1 Heterozygous Mutation in Tumor
Qian Li, Tao Sun, Hua Zhang, Wei Liu +11 more
2022Zhongguo fei ai za zhi = Chinese journal of lung cancer2 citations
Semantic Scholar
Clinical value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification of lung adenocarcinoma
Ziwei Guo, F. Yi, Wen-Cheng Yin, Yu Zhang +6 more
2017Thoracic Cancer2 citations Open access
Semantic Scholar
Clinical efficacy and cardiac toxicity associated with first-line dabrafenib plus trametinib in advanced BRAF V600_K601delinsE-mutated lung adenocarcinoma: a case report and literature review
Lu Yang, Xuanjun Liu, Xiang Zhu, B. Cao +2 more
2026Discover Oncology1 citations Open access
Semantic Scholar
A comprehensive comparison of third generation epidermal growth factor receptor tyrosine kinase inhibitors in the treatment efficacy and adverse events: A Bayesian meta-analysis
Jin-Yu Yu, Hanyu Wu, Lu Yang, Wei Liu +3 more
2025Global Medical Genetics1 citations Open access
Semantic Scholar
Programmed death-ligand 1 tumor proportion score in predicting the safety and efficacy of PD-1/PD-L1 antibody-based therapy in patients with advanced non-small cell lung cancer: A retrospective, multicenter, observational study
Yuequan Shi, Xiao-Yan Liu, An-Wen Liu, Jian Fang +19 more
2025Chinese Medical Journal1 citations Open access
Semantic Scholar
Maintenance Therapy with Pembrolizumab after Platinum-Doublet Chemotherapy Leading to Hyperprogression in a Patient with Metastatic Bladder Cancer
Yang-Chun Gu, Hui-Ying He, Mo-Pei Wang
2021Asia-Pacific Journal of Oncology Nursing1 citations Open access
Semantic Scholar
Nrf2、Keap1蛋白在104例肺腺癌中的表达及其临床病理特征
Yu Xiao, Xiang Zhu, Yang-Chun Gu, Sen Chen +2 more
2018Zhongguo fei ai za zhi = Chinese journal of lung cancer1 citations
Semantic Scholar
Ring-like diffusion restriction in a pyogenic liver abscess in a nonagenarian: a diagnostic pitfall on diffusion-weighted imaging.
Tianyu Yang, Yang-Chun Gu, Yu Geng, Yuan-Hao Xia +2 more
2026Polish Archives of Internal Medicine0 citations Open access
Semantic Scholar
Real-world study of first-line immunotherapy for EGFR/ALK wild-type advanced NSCLC: Analysis from the China National Cancer Center database.
Yang-Chun Gu, Baoshan Cao
2026Journal of Clinical Oncology0 citations
Semantic Scholar
Chinese Expert Consensus on Immune Checkpoint Inhibitor Therapy for Elderly Patients with Advanced Non‐small Cell Lung Cancer (2025 Edition)
Lin Li, X. Nie, Q. Wei, Xu Li +11 more
2026Aging Medicine0 citations Open access
Semantic Scholar
Landscape of the immune microenvironment in malignant pleural effusion from EGFR-TKI-resistant NSCLC.
Yang-Chun Gu, Abudureyimujiang Aili, Zhen-Tao Liu, Lu Yang +3 more
2026Journal of Clinical Oncology0 citations
Semantic Scholar
Predictive Value of Patient-Derived Tumor Cell Cluster–Based Drug Sensitivity Assay in Advanced NSCLC
Yang-Chun Gu, Lei-Lei Yang, Hua Zhang, Shen-Yi Yin +6 more
2025Clinical Medicine Insights: Oncology0 citations Open access
Semantic Scholar
Clinical outcomes of patients with advanced NSCLC with different EGFR exon 19 deletion subtypes treated with first-line tyrosine kinase inhibitors.
Yang-Chun Gu, Jin-Yu Yu, Haifeng Hu, Hua Zhang +2 more
2023Journal of Clinical Oncology0 citations
Semantic Scholar
[Clinical Characteristics and Prognosis of 76 Lung Adenocarcinoma Patients Harboring EGFR Mutations with Pleural Effusion at Initial Diagnosis: A Single-center Retrospective Study].
Wen-Cheng Yin, Hua Zhang, Yang-Chun Gu, F. Yi +5 more
2022Zhongguo fei ai za zhi = Chinese journal of lung cancer0 citations
Semantic Scholar
[Clinical analysis of 121 cases of urothelial carcinoma accompanied with multiple primary carcinoma].
Yang-Chun Gu, Jian-Fei Ye, Bao-Shan Cao, Mo-Pei Wang +2 more
2019Zhonghua zhong liu za zhi [Chinese journal of oncology]0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Bao-Shan Cao×12
Invite
Bao-Shan Cao — researcher profile on SciRah
F. Yi×7
Invite
F. Yi — researcher profile on SciRah
L. Liang×6
Invite
L. Liang — researcher profile on SciRah
Hua Zhang×6
Invite
Hua Zhang — researcher profile on SciRah

×6

Invite

L. Liang — researcher profile on SciRah

Invite

Yan'e Liu — researcher profile on SciRah

Invite

Jin-Yu Yu — researcher profile on SciRah

Meng-Zhao Wang×5

Invite

Meng-Zhao Wang — researcher profile on SciRah

Wen-Cheng Yin×5

Invite

Wen-Cheng Yin — researcher profile on SciRah

Zhen-Tao Liu×5

Invite

Zhen-Tao Liu — researcher profile on SciRah

Invite

Jun-Ling Li — researcher profile on SciRah

Min-Jiang Chen×4

Invite

Min-Jiang Chen — researcher profile on SciRah